Cystic fibrosis patients with the 3272‐26A→G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Human Mutation

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1098-1004(1999)14:2<133::AID-HUMU5>3.0.CO;2-TPMID 10425036
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways.

  1998influential reference
• Chloride channel and chloride conductance regulator domains of CFTR, the cystic fibrosis transmembrane conductance regulator.

  1998cited by this paper
• Peptide binding consensus of the NHE‐RF‐PDZ1 domain matches the C‐terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR)

  1998cited by this paper
• An Apical PDZ Protein Anchors the Cystic Fibrosis Transmembrane Conductance Regulator to the Cytoskeleton*

  1998cited by this paper
• The regulation of splice-site selection, and its role in human disease.

  1997cited by this paper
• Missense mutation R1066C in the second transmembrane domain of CFTR causes a severe cystic fibrosis phenotype: Study of 19 heterozygous and 2 homozygous patients

  1997cited by this paper
• A method for the rapid detection of recombinant CFTR during gene therapy in cystic fibrosis.

  1996cited by this paper
• New pharmaceutical approaches to the treatment of cystic fibrosis

  1996cited by this paper
• Complex cystic fibrosis allele R334W‐R1158X results in reduced levels of correctly processed mRNA in a pancreatic sufficient patient

  1996cited by this paper
• Haplotype analysis of 94 cystic fibrosis mutations with seven polymorphic CFTR DNA markers

  1996influential reference
• Transcript analysis of CFTR nonsense mutations in lymphocytes and nasal epithelial cells from cystic fibrosis patients

  1995cited by this paper
• Frequent Occurrence of the CFTR Intron 8 (TG)n 5T Allele in Men with Congenital Bilateral Absence of the Vas Deferens

  1995cited by this paper
• Severe cystic fibrosis phenotype in a delta F508/3272-26A-->G compound heterozygote.

  1995influential reference
• Mild cystic fibrosis phenotype in patients with the 3272-26A > G mutation.

  1995cited by this paper
• Cystic fibrosis: genotypic and phenotypic variations.

  1995cited by this paper
• Polarized epithelial cells of the hamster seminal vesicle in a serum-free bicameral culture system: evidence of secretory and endocytic activities

  1995cited by this paper
• Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator.

  1994cited by this paper
• Detection of more than 50 different CFTR mutations in a large group of German cystic fibrosis patients

  1994cited by this paper
• The amino-terminal portion of CFTR forms a regulated CI− channel

  1994cited by this paper
• A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations.

  1994cited by this paper
• The amino-terminal portion of CFTR forms a regulated Cl- channel.

  1994cited by this paper
• Mechanism of sodium hyperabsorption in cultured cystic fibrosis nasal epithelium: a patch-clamp study.

  1994influential reference
• CFTR haplotype backgrounds on normal and mutant CFTR genes.

  1994influential reference
• The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment.

  1993cited by this paper
• Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions.

  1992influential reference
• Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive

  1992cited by this paper
• Chloride channels in the apical membrane of normal and cystic fibrosis airway and intestinal epithelia.

  1992influential reference
• Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene.

  1992cited by this paper
• Cystic fibrosis: molecular biology and therapeutic implications.

  1992cited by this paper
• Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population.

  1992cited by this paper
• Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland.

  1992cited by this paper
• Human pre-mRNA splicing signals.

  1991cited by this paper
• Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2

  1991cited by this paper
• Immunocytochemical localization of the cystic fibrosis gene product CFTR.

  1991cited by this paper
• Lymphocyte mRNA as a resource for detection of mutations and polymorphisms in the CF gene.

  1991cited by this paper
• Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis.

  1991cited by this paper
• Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

  1991cited by this paper
• Regulated mRNA stability.

  1990cited by this paper
• Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.

  1990cited by this paper
• Identification of the cystic fibrosis gene: genetic analysis

  1989cited by this paper
• Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA

  1989cited by this paper
• Identification of the cystic fibrosis gene: chromosome walking and jumping.

  1989cited by this paper
• Identification of the cystic fibrosis gene: genetic analysis.

  1989cited by this paper
• Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

  1989cited by this paper
• Identification of the cystic fibrosis gene: Chromosome walking and jumping

  1989cited by this paper
• RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression.

  1987cited by this paper
• Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation.

  1986cited by this paper
• A catalogue of splice junction sequences.

  1982cited by this paper

• Rectal organoid morphology analysis (ROMA) as a novel physiological assay for diagnostic classification in cystic fibrosis

  2024cites this paper
• Phenotypic Evaluation of Rare Cystic Fibrosis Transmembrane Conductance Regulator Mutation Combinations in People with Cystic Fibrosis in Queensland, Australia

  2024cites this paper
• Use of genome sequencing to hunt for cryptic second-hit variants: analysis of 31 cases recruited to the 100 000 Genomes Project

  2023cites this paper
• Molecular and functional correction of a deep intronic splicing mutation in CFTR by CRISPR-Cas9 gene editing

  2023cites this paper
• Precision Medicine Based on CFTR Genotype for People with Cystic Fibrosis

  2022cites this paper
• Molecular mechanisms of cystic fibrosis – how mutations lead to misfunction and guide therapy

  2022cites this paper
• Health Characteristics of Patients with Cystic Fibrosis whose Genotype Includes a Variant of the Nucleotide Sequence c.3140-16T>A and Functional Analysis of this Variant

  2021cites this paper
• Rare Trafficking CFTR Mutations Involve Distinct Cellular Retention Machineries and Require Different Rescuing Strategies

  2021cites this paper
• Cystic Fibrosis Human Organs-on-a-Chip

  2021cites this paper
• Cystic Fibrosis

  2021cites this paper
• PROCEEDINGS OF THE 17thITALIAN CONVENTION OF FFC INVESTIGATORS IN CYSTIC FIBROSIS

  2020cites this paper
• New Directions in Pulmonary Gene Therapy

  2020cites this paper
• Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease

  2020cites this paper
• The Effect of Synonymous Single-Nucleotide Polymorphisms on an Atypical Cystic Fibrosis Clinical Presentation

  2020cites this paper
• Genotype patterns for mutations of the cystic fibrosis transmembrane conductance regulator gene: a retrospective descriptive study from Saudi Arabia

  2020cites this paper
• Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing

  2019cites this paper
• Minigene assay to Evaluate CRISPR/Cas9-based excision of Intronic mutations that Cause Aberrant Splicing in Human Cells.

  2019cites this paper
• Correction of the ΔF508 mutation in the CFTR Gene by CRISPR/Cas9 system

  2018cites this paper
• Predicting gene structure changes resulting from genetic variants via exon definition features

  2018cites this paper
• The effect of premature termination codon mutations on CFTR mRNA abundance in human nasal epithelium and intestinal organoids: a basis for read‐through therapies in cystic fibrosis

  2018cites this paper
• Brain transcriptome analyses of paternal-specific mutant GRB10KO and potential insights into dominance behaviour

  2018cites this paper
• Diagnosis, Prognosis and Personalized Treatment of Cystic Fibrosis

  2018cites this paper
• mRNA‐based detection of rare CFTR mutations improves genetic diagnosis of cystic fibrosis in populations with high genetic heterogeneity

  2017cites this paper
• Study and characterization of CFTR mutations in vitro and in native tissues from non CF patients with chronic airways diseases

  2017cites this paper
• Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA

  2017cites this paper
• An Integrative Genomic Study of Dupuytren's Disease

  2016cites this paper
• Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products.

  2016cites this paper
• Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients

  2015cites this paper
• Estratègies terapèutiques per la Neurofibromatosi de tipus 1

  2014cites this paper
• Chapter 58 – Cystic Fibrosis

  2013cites this paper
• Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene

  2013cites this paper
• Cystic fibrosis gene repair: correction of ΔF508 using ZFN and CRISPR/Cas9 guide RNA gene editing tools

  2013cites this paper
• Changes in transcriptome of native nasal epithelium expressing F508del-CFTR and intersecting data from comparable studies

  2013cites this paper
• Assessing the residual CFTR gene expression in human nasal epithelium cells bearing CFTR splicing mutations causing cystic fibrosis

  2013cites this paper
• Measurements of CFTR-Mediated Cl− Secretion in Human Rectal Biopsies Constitute a Robust Biomarker for Cystic Fibrosis Diagnosis and Prognosis

  2012cites this paper
• Chronic Obstructive Pulmonary Disease and Proteomics: A Match for

  2012cites this paper
• Chronic Obstructive Pulmonary Disease and Proteomics: A Match for Success?

  2012cites this paper
• Detection of a large heterozygous deletion and a splicing defect in the CFTR transcripts from nasal swab of a Japanese case of cystic fibrosis

  2012cites this paper
• Specific correction of a splice defect in brain by nutritional supplementation.

  2011cites this paper
• Correlação entre aspectos clínicos, moleculares e fisiológicos de pacientes adultos com hipótese diagnóstica de fibrose cística de um centro de referência no Brasil

  2011cites this paper
• Chronic obstructive pulmonary disease : a proteomics approach

  2011influential citation
• A mild neurofibromatosis type 1 phenotype produced by the combination of the benign nature of a leaky NF1‐splice mutation and the presence of a complex mosaicism

  2011cites this paper
• F508del-CFTR increases intracellular Ca(2+) signaling that causes enhanced calcium-dependent Cl(-) conductance in cystic fibrosis.

  2011cites this paper
• SELDI-TOF biomarker signatures for cystic fibrosis, asthma and chronic obstructive pulmonary disease.

  2010cites this paper
• Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease.

  2009cites this paper
• A novel double deletion underscores the importance of characterizing end points of the CFTR large rearrangements

  2009cites this paper
• Pharmacological Rescue of Mutant CFTR Function for the Treatment of Cystic Fibrosis

  2008cites this paper
• Molecular and Functional Characterization of CBAVD-Causing Mutations Located in CFTR Nucleotide-Binding Domains

  2008cites this paper
• The Molecular Basis of Familial Dysautonomia: Overview, New Discoveries and Implications for Directed Therapies

  2007cites this paper
• Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia

  2007cites this paper
• High incidence of the CFTR mutations 3272-26A-->G and L927P in Belgian cystic fibrosis patients, and identification of three new CFTR mutations (186-2A-->G, E588V, and 1671insTATCA).

  2007cites this paper
• Proteomic analysis of nasal cells from cystic fibrosis patients and non‐cystic fibrosis control individuals: Search for novel biomarkers of cystic fibrosis lung disease

  2006cites this paper
• Splicing modulation as a modifier of the CFTR function.

  2006cites this paper
• Processing of CFTR: Traversing the cellular maze—How much CFTR needs to go through to avoid cystic fibrosis?

  2005cites this paper
• Biased exon/intron distribution of cryptic and de novo 3′ splice sites

  2005cites this paper
• Cystic Fibrosis--clinical features of a sample of Portuguese patients.

  2005cites this paper
• MAASE: an alternative splicing database designed for supporting splicing microarray applications.

  2005cites this paper
• A novel missense mutation P1290S at exon-20 of the CFTR gene in a Portuguese patient with congenital bilateral absence of the vas deferens.

  2005cites this paper
• Fibrose quística – Caracterização clínica de uma amostra de doentes portugueses

  2005cites this paper
• Ionic transport in tall columnar epithelial (TCE) cells obtained by nasal brushing from non-cystic fibrosis (CF) individuals.

  2004cites this paper
• Immunohistochemistry of CFTR in native tissues and primary epithelial cell cultures.

  2004cites this paper
• Methods for RNA extraction, cDNA preparation and analysis of CFTR transcripts.

  2004cites this paper
• A gene locus for branchio-otic syndrome maps to chromosome 14q21.3-q24.3.

  2003cites this paper
• High frequency of T9 and CFTR mutations in children with idiopathic bronchiectasis

  2003cites this paper
• Transcript analysis of the cystic fibrosis splicing mutation 1525-1G>A shows use of multiple alternative splicing sites and suggests a putative role of exonic splicing enhancers

  2003cites this paper
• CFTR genotypes in patients with normal or borderline sweat chloride levels

  2003cites this paper
• EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia.

  2003cites this paper
• Alterations of the Birt-Hogg-Dubé gene (BHD) in sporadic colorectal tumours

  2003cites this paper
• FMRP expression studies in blood and hair roots in a fragile X family with methylation mosaics.

  2003cites this paper
• Tocotrienols induce IKBKAP expression: a possible therapy for familial dysautonomia.

  2003cites this paper
• Applicability of Different Antibodies for the Immunohistochemical Localization of CFTR In Respiratory and Intestinal Tissues of Human and Murine Origin

  2003cites this paper
• Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.

  2002cites this paper
• The molecular basis of cystic fibrosis in South Africa

  2001cites this paper
• Cystic fibrosis patients with the 3272-26A>G splicing mutation have milder disease than F508del homozygotes: a large European study

  2001cites this paper
• Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A→G, 2751+2T→A, 296+1G→C, 1717–9T→C-D565G) and one nonsense mutation (E822X) in the CFTR gene

  2001cites this paper
• Molecular screening of the CFTR gene in men with anomalies of the vas deferens: identification of three novel mutations.

  2000cites this paper
• Cystic Fibrosis F508del Patients Have Apically Localized CFTR in a Reduced Number of Airway Cells

  2000cites this paper
• Molecular Evolution: Towards the Origin of Metazoa

  1998cites this paper